US firm has FDA approval for pill coating

27 August 2006

The US Food and Drug Adminstration has approved a request by EMD Chemicals, a USA-based subsidiary of German drugmaker Merck KGaA, to add new color pigments to pills and tablets, including shimmering and other effects.

Dan Giambattisto, sales and marketing director at the Gibbstown, New Jersey-based chemical firm told local media: "our materials aren't generally used in the actual pill. What we're doing is adding another coating to give it a pearly effect or luster." He added that he expects considerable demand for the product.

Industry observers see the new pigments as offering effective means of making counterfeiting easier to detect and help patients to discriminate between different medications that they may have been prescribed for simultaneous treatment.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight